The Promise of Biosimilar Drugs

The Promise of Biosimilar Drugs

In 2006, the European Medicines Agency granted its first approval of a biosimilar drug, the human growth hormone, Omnitrope™ (Sandoz), and opened the doors of opportunity for this emerging field of medicine. In 2010, President Obama signed into law the Biosimilars...
Making Room for Biosimilars

Making Room for Biosimilars

Co-authored by Stephanie Finnegan, President Divisional Operations and Dominique James, Editorial Analyst On March 6th, 2015 the FDA announced approval of the first Biosimilar drug in the United States. The similarities between follow-on drugs and follow-on biologics...